The Power to Divide
Tags: STEM cells; LEUKEMIA; BONE marrow -- Transplantation; CYTOLOGY -- Research; IMMUNE system
Related Articles
- G-CSF increases the number of peripheral blood dendritic cells CD16+ and modifies the expression of the costimulatory molecule CD86+. Talarn, C.; Urbano-Ispizua, A.; Martino, R.; Batlle, M.; Fern�ndez-Avil�s, F.; Herrera, C.; P�rez-Sim�n, J. A.; Gaya, A.; Aymerich, M.; P.�triz, J.; Mar�n, P.; Sierra, J.; Montserrat, E. // Bone Marrow Transplantation;May2006, Vol. 37 Issue 9, p873
Dendritic cells (DC) play a key role in initiating immune reactions after allogeneic stem cell transplantation. The two main peripheral blood DC populations are myeloid (DC1) and lymphoplasmacytoid (DC2). A new subset of myeloid DC, expressing CD16, has been identified. We analyzed the number...
- Bone marrow reconstitution with normal autologous cells demonstrated by VNTR analysis after allogeneic bone marrow transplatation for chronic myelogenous leukemia. del Rosario Uriarte, M; Bonomi, R; Azambuja, C; Seu�nez, H N // Leukemia (08876924);Dec97, Vol. 11 Issue 12, p2213
Discusses that la stem cell transplantation is the only procedure for a successful cure of chronic myeloid leukemia (CML). Significance of bone marrow transplantation in CML; Molecular biology of CML; Importance of monitoring the relapse after allogeneic bone marrow transplantation.
- The International Myeloma Foundation: Study Says Long-Term Maintenance Treatment Demonstrates 90% Overall Survival Rate. // Biomedical Market Newsletter;5/9/2011, p197
The article discusses a study by the International Myeloma Foundation (IMF), the oldest and largest foundation dedicated to improving the life and care of myeloma patients, on the REVLIMID maintenance therapy following stem cell (bone marrow) transplant. The study indicated that REVLIMID...
- 14. Chronic Leukemia. // Bone Marrow Transplantation;3/2/2002 Supplement, Vol. 29 Issue 5, pS161
Bone Marrow Transplantation (2001) 29, Suppl. 2, S161�S166. DOI: 10.1038/sj/bmt/1703480
- AML / MDS. // Bone Marrow Transplantation;3/2/2002 Supplement, Vol. 29 Issue 5, pS54
Bone Marrow Transplantation (2001) 29, Suppl. 2, S54�S57. DOI: 10.1038/sj/bmt/1703457
- Double allogeneic peripheral stem cell transplants for patients at high risk of relapse. Passweg, J R; Hoffmann, T; Tichelli, A; Favre, G; Rohner, F; Gratwohl, A // Bone Marrow Transplantation;8/15/98, Vol. 22 Issue 4, p321
Patients with chronic myeloid leukemia (CML) relapsing in blast crisis after HLA-identical sibling bone marrow transplantation (BMT) are difficult to treat. Infusion of donor lymphocytes or retransplantation are unlikely to result in long-term disease-free survival. Treatment intensification...
- ABSTRACTS. // Leukemia (08876924);Mar2002, Vol. 16 Issue 3, p406
Presents abstracts of articles related to leukemia. CD34+ selected haploidentical hematopoietic stem cell transplants at the Mayo Clinic in Rochester, Minnesota; Mismatched transplants; Maximization of CD34 dose and minimization of CD3 dose in T cell depleted bone marrow and peripheral blood...
- Quick guide to... Bone marrow transplants. // Children & Young People Now;10/8/2009, p23
The article offers information on the basic concepts of bone marrow transplants. It states that the bone marrow transplants are often the last resort for patients suffering from leukaemia and defect primary immunodeficiency (PID). Moreover, the transplantation involves taking healthy stem cells...
- Lymphocyte recovery after allogeneic bone marrow transplantation predicts risk of relapse in acute lymphoblastic leukemia. Kumar, S.; Chen, M.G.; Gastineau, D.A.; Gertz, M.A.; Inwards, D.J.; Lacy, M.Q.; Tefferi, A.; Litzow, M.R. // Leukemia (08876924);Sep2003, Vol. 17 Issue 9, p1865
Allogeneic blood and marrow transplantation (BMT) is curative for many patients with high-risk and relapsed acute lymphoblastic leukemia (ALL). However, relapse is an important cause of post-transplantation failure, and there are no reliable markers to predict relapse. A retrospective review of...
